These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 19062216)

  • 1. Determination of tropicamide and its major impurity in raw material by the HPLC-DAD analysis and identification of this impurity using the off-line HPLC-FT-IR coupling.
    Stefanowicz Z; Stefanowicz J; Mulas K
    J Pharm Biomed Anal; 2009 Feb; 49(2):214-20. PubMed ID: 19062216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impurity profile study of lopinavir and validation of HPLC method for the determination of related substances in lopinavir drug substance.
    Chitturi SR; Bharathi Ch; Reddy AV; Reddy KC; Sharma HK; Handa VK; Dandala R; Bindu VH
    J Pharm Biomed Anal; 2008 Dec; 48(5):1430-40. PubMed ID: 18947954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural elucidation of the Rifaximin Ph. Eur. Impurity H.
    Stradi R; Nava D; Nebuloni M; Pastura B; Pini E
    J Pharm Biomed Anal; 2010 Mar; 51(4):858-65. PubMed ID: 19926422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification, synthesis, isolation and spectral characterization of potential impurities of montelukast sodium.
    Saravanan M; Siva Kumari K; Pratap Reddy P; Naidu MN; Moses Babu J; Srivastava AK; Lakshmi Kumar T; Chandra Sekhar BV; Satyanarayana B
    J Pharm Biomed Anal; 2008 Nov; 48(3):708-15. PubMed ID: 18755563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Forced degradation and impurity profiling: recent trends in analytical perspectives.
    Jain D; Basniwal PK
    J Pharm Biomed Anal; 2013 Dec; 86():11-35. PubMed ID: 23969330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-performance liquid chromatographic determination of phenylephrine and tropicamide in human aqueous humor.
    Galmier MJ; Frasey AM; Meski S; Beyssac E; Petit J; Aiache JM; Lartigue C
    Biomed Chromatogr; 2000 May; 14(3):202-4. PubMed ID: 10850625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and characterization of new impurity in didanosine.
    Srinivasa Rao DV; Srinivas N; Bharathi Ch; Prasad ChS; Dandala R; Naidu A
    J Pharm Biomed Anal; 2007 Nov; 45(3):516-20. PubMed ID: 17624711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impurity profile study of zaleplon.
    Bharathi Ch; Prabahar KJ; Prasad ChS; Kumar MS; Magesh S; Handa VK; Dandala R; Naidu A
    J Pharm Biomed Anal; 2007 May; 44(1):101-9. PubMed ID: 17367980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation and Characterization of an Unknown Process-Related Impurity in Furosemide and Validation of a New HPLC Method.
    Xu A; Xue Y; Zeng Y; Li J; Zhou H; Wang Z; Chen Y; Chen H; Jin J; Zhuang T
    Molecules; 2023 Mar; 28(5):. PubMed ID: 36903659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low level determination of 4-amino-2-ethoxy-cinnamic acid and its ethyl ester in a drug substance and its formulation prototypes by HPLC-UV-DAD.
    Soman A; Jacob S; Swanek F
    J Chromatogr Sci; 2009 Apr; 47(4):315-9. PubMed ID: 19406019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation and characterization of a potential process related impurity of phenazopyridine HCl by preparative HPLC followed by MS-MS and 2D-NMR spectroscopy.
    Rao RN; Maurya PK; Raju AN
    J Pharm Biomed Anal; 2009 Jul; 49(5):1287-91. PubMed ID: 19376664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis and evaluation of the impurity of felodipine and its tablets].
    Zhang N; Yu LJ; Li J; Tong JW; Meng J; Zhang QM; Shi YQ
    Yao Xue Xue Bao; 2012 Feb; 47(2):223-8. PubMed ID: 22512035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural identification and characterization of impurities in ceftizoxime sodium.
    Bharathi Ch; Prasad ChS; Bharathi DV; Shankar R; Rao VJ; Dandala R; Naidu A
    J Pharm Biomed Anal; 2007 Jan; 43(2):733-40. PubMed ID: 16950586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation and characterization of some potential impurities in ropinirole hydrochloride.
    Sahasrabuddhey B; Nautiyal R; Acharya H; Khyade S; Luthra PK; Deshpande PB
    J Pharm Biomed Anal; 2007 Mar; 43(4):1587-93. PubMed ID: 17207602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification, characterization and quantification of a new impurity in deferasirox active pharmaceutical ingredient by LC-ESI-QT/MS/MS.
    Thomas S; Chandra Joshi S; Vir D; Agarwal A; Rao RD; Sridhar I; Xavier CM; Mathela CS
    J Pharm Biomed Anal; 2012 Apr; 63():112-9. PubMed ID: 22361658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification, isolation and characterization of impurities of clindamycin palmitate hydrochloride.
    Bharathi Ch; Jayaram P; Sunder Raj J; Saravana Kumar M; Bhargavi V; Handa VK; Dandala R; Naidu A
    J Pharm Biomed Anal; 2008 Dec; 48(4):1211-8. PubMed ID: 18947955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the trace-level impurities in the bulk drug citalopram by high-performance liquid chromatography/tandem multistage mass spectrometry.
    Sun C; Xu H; Pan Y; Shen Z; Wang D
    Rapid Commun Mass Spectrom; 2007; 21(17):2889-94. PubMed ID: 17663502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification, isolation, synthesis and characterization of impurities of quetiapine fumarate.
    Bharathi Ch; Prabahar KJ; Prasad ChS; Srinivasa Rao M; Trinadhachary GN; Handa VK; Dandala R; Naidu A
    Pharmazie; 2008 Jan; 63(1):14-9. PubMed ID: 18271296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification, characterization and quantification of new impurities by LC-ESI/MS/MS and LC-UV methods in rivastigmine tartrate active pharmaceutical ingredient.
    Thomas S; Shandilya S; Bharati A; Paul SK; Agarwal A; Mathela CS
    J Pharm Biomed Anal; 2012 Jan; 57():39-51. PubMed ID: 21880452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analytical developments of p-hydroxy prenylamine reference material for dope control research: Characterization and purity assessment.
    Joseph A; Kumar GJ; Pawar SD; Hirlekar BU; Bharatam PV; Konda S; Mudiam MKR; Murty US; Sahu PL; Dubey S; Radhakrishnanand P; Adye DR; Borkar RM; Thirupathi C; Kumar P
    Drug Test Anal; 2022 Feb; 14(2):224-232. PubMed ID: 34617411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.